Home > Healthcare > Medical Devices > Therapeutic Devices > Drug-eluting Balloon Catheters Market

Drug-eluting Balloon Catheters Market Trends

Report ID: GMI5243
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Drug-eluting Balloon Catheters Market Trends

Improved drug delivery systems, biodegradable technologies, and customized drug formulations among other key technological advancements are anticipated to shape the industry.

Improved mechanical properties, such as increased flexibility and better navigation, contribute to more precise interventions and increased efficacy of drug delivery. Enhanced drug delivery systems result in more targeted and controlled release of therapeutic agents, improving the effectiveness of drug-eluting balloon catheters in preventing restenosis.
Development of advanced coatings, including nano-coatings and biodegradable polymers contribute to better adhesion, controlled drug release kinetics, and improved biocompatibility.

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for drug-eluting balloon catheters was valued at around USD 582 million in 2022 and will surpass USD 1.7 billion by 2032, driven by advancements in drug delivery technologies, preference for minimally invasive procedures, and increasing incidence of cardiovascular diseases.

The hospitals and clinics segment accounted for a majority share in 2022 and is projected to reach over USD 964 million in 2032 driven by favourable reimbursement policies for procedures involving drug-eluting balloon catheters.

North America market accounted for USD 254.9 million in 2022 and is anticipated to record healthy growth through 2032 driven by an aging population, and growing awareness among healthcare professionals and patients about advanced interventional options.

Aachen Resonance GmbH, B. Braun Melsungen AG, Becton, Dickinson and Company, Biosensors International, Biotronik AG are some of the major industry contenders.